-
Article
Open AccessA prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
Patients with hepatocellular carcinoma waiting for liver transplantation are commonly treated with locoregional treatments, such as TACE and ablation, to prevent tumor progression and dropout and to improve lo...
-
Article
Open AccessErratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
-
Article
Open AccessIsolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
Uveal melanoma is the most common primary intraocular malignancy in adults. Despite successful control of the primary tumor, metastatic disease will ultimately develop in approximately 50% of patients, with th...
-
Chapter
The Impact of Inflammation Control and Active Cancer Palliation on Metabolic Pathways Determining Tumor Progression and Patient Survival
Strong associations are assumed between inflammation, cancer initiation, and tumor progression. Weight loss and cachexia predispose for early death in cancer disease. Usually, such cachexia conditions are char...
-
Article
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
Hepatocellular cancer (HCC), as well as cholangiocellular cancer (CCC), has an extremely poor prognosis due to the extent of tumor at diagnosis and the underlying liver disease. Sirolimus is used in the transp...
-
Article
Indications and Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Metastases from neuroendocrine (NE) tumors of the gastrointestinal tract, carcinoids, and endocrine pancreatic tumors (EPTs) can be confined to the liver for long periods and may exhibit slow growth. When con...
